Strategic Approaches in Formulation Development for Atopic Dermatitis
Abstract
:1. Introduction
2. Rationale for the Development of a Topical Vehicle for Drug Delivery
3. Key Vehicle Forms for Topical Drug Therapy
3.1. Creams
3.2. Lotions
Topical Formulations | Aspect | Application Area | Effect | Key Features |
---|---|---|---|---|
Creams [41,45] | semisolid emulsion | face and localized areas | moisturizer and a non-greasy sensation | no obstruction to heat dissipation |
Lotions [44] | fluid emulsion | skin, body, and scalp | cooling effect | easy application |
Ointments [43] | oily | specific area | occlusive effect | one phase vehicle |
Gels [6,43] | thick gel | oily skin or areas with hair | film-like effect on the skin | easy removal |
Foam [6,49] | aerated foam | sensitive skin | pleasant effect | reaches large areas |
Spray [6,50] | solution aerosol | skin body, and scalp | cooling sensation | reaches large areas, may cause a burning and stinging sensation |
Shampoo/Soap [41] | solid or liquid | skin, scalp | cleaning effect | reaches large areas |
Paste [41] | semisolid, stiff consistency | skin, oral cavity, mucous membrane | occlusive and protective actions | skin protection and absorb secretions |
3.3. Ointments
3.4. Gels
3.5. Pastes
3.6. Foam
3.7. Spray
3.8. Shampoo/Soap
4. Cosmetics as Adjuvants
5. Cosmetic Formulations
6. Moisturizers
7. Effects of Formulation Excipients
7.1. Solvents
7.2. Consistency Agents
7.3. Thickeners/Gelling Agents
- Lipid thickeners (cetyl alcohol, cetearyl alcohol, stearic acid, and carnauba wax) are incorporated into the oily phase of the formulation due to their lipidic nature.
- Natural thickeners (hydroxyethyl cellulose, carboxymethyl cellulose, guar gum, xanthan gum, gelatin, and sodium alginate) are polymers that absorb water thereby increasing the viscosity of the vehicle.
- Mineral thickeners (silica, aluminum magnesium silicate, and bentonite) are of natural origin, absorbing water, and oils to increase the viscosity of the formulation.
7.4. Silicones
7.5. Humectants
7.6. Emulsifiers/Solubilisers
7.7. Chelating Agents
7.8. Acidifying, Alkalising, or Buffering Agent
7.9. Antioxidants
7.10. Preservatives
7.11. Fragrance
8. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Yang, G.; Seok, J.K.; Kang, H.C.; Cho, Y.-Y.; Lee, H.S.; Lee, J.Y. Skin barrier abnormalities and immune dysfunction in atopic dermatitis. Int. J. Mol. Sci. 2020, 21, 2867. [Google Scholar] [CrossRef] [PubMed]
- Abd, E.; Yousef, S.A.; Pastore, M.N.; Telaprolu, K.; Mohammed, Y.H.; Namjoshi, S.; Grice, J.E.; Roberts, M.S. Skin models for the testing of transdermal drugs. Clin. Pharmacol. Adv. Appl. 2016, 8, 163–176. [Google Scholar] [CrossRef] [PubMed]
- Prescott, S.L.; Larcombe, D.L.; Logan, A.C.; West, C.; Burks, W.; Caraballo, L.; Levin, M.; Etten, E.V.; Horwitz, P.; Kozyrskyj, A.; et al. The skin microbiome: Impact of modern environments on skin ecology, barrier integrity, and systemic immune programming. World Allergy Organ J. 2017, 10, 29. [Google Scholar] [CrossRef] [PubMed]
- Lee, S.H.; Jeong, S.K.; Ahn, S.K. An update of the defensive barrier function of skin. Yonsei Med. J. 2006, 47, 293. [Google Scholar] [CrossRef] [PubMed]
- Lod´en, M. Role of Topical Emollients and Moisturizers in the Treatment of Dry Skin Barrier Disorders. Am. J. Clin. Dermatol. 2012, 4, 771–788. [Google Scholar] [CrossRef] [PubMed]
- Barnes, T.M.; Mijaljica, D.; Townley, J.P.; Spada, F.; Harrison, I.P. Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison. Pharmaceutics 2021, 13, 2012. [Google Scholar] [CrossRef]
- Al-Smadi, K.; Leite-Silva, V.R.; Filho, N.A.; Lopes, P.S.; Mohammed, Y. Innovative Approaches for Maintaining and Enhancing Skin Health and Managing Skin Diseases through Microbiome-Targeted Strategies. Antibiotics 2023, 12, 1698. [Google Scholar] [CrossRef]
- Avena-Woods, C. Overview of atopic dermatitis. Am. J. Manag. Care 2017, 23, S115–S123. [Google Scholar] [PubMed]
- Bieber, C.; Müller, K.G.; Nicolai, J.; Hartmann, M.; Eich, W. How does your doctor talk with you? Preliminary validation of a brief patient self-report questionnaire on the quality of physician–patient interaction. J. Clin. Psychol. Med. Settings 2010, 17, 125–136. [Google Scholar] [CrossRef]
- Drucker, A.M.; Wang, A.R.; Li, W.Q.; Sevetson, E.; Block, J.K.; Qureshi, A.A. The Burden of Atopic Dermatitis: Summary of a Report for the National Eczema Association. J. Invest. Dermatol. 2017, 137, 26–30. [Google Scholar] [CrossRef]
- Bjerre, R.D.; Bandier, J.; Skov, L.; Engstrand, L.; Johansen, J.D. The role of the skin microbiome in atopic dermatitis: A systematic review. Br. J. Dermatol. 2017, 177, 1272–1278. [Google Scholar] [CrossRef]
- Eichenfield, L.F.; Tom, W.L.; Chamlin, S.L.; Feldman, S.R.; Hanifin, J.M.; Simpson, E.L.; Berger, T.G.; Bergman, J.N.; Cohen, D.E.; Cooper, K.D.; et al. Guidelines of care for the management of atopic dermatitis: Section 1. Diagnosis and assessment of atopic dermatitis. J. Am. Acad. Dermatol. 2014, 70, 338–351. [Google Scholar] [CrossRef]
- Nutten, S. Atopic dermatitis: Global epidemiology and risk factors. Ann. Nutr. Metab. 2015, 66 (Suppl. S1), 8–16. [Google Scholar] [CrossRef]
- Ali, F.; Vyas, J.; Finlay, A.Y. Counting the Burden: Atopic Dermatitis and Health-related Quality of Life. Acta Derm. Venereol. 2020, 100, 5766. [Google Scholar] [CrossRef]
- Blome, C.; Radtke, M.A.; Eissing, L.; Augustin, M. Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit. Am. J. Clin. Dermatol. 2016, 17, 163–169. [Google Scholar] [CrossRef] [PubMed]
- Imran, M.; Jin, X.; Ali, M.; Tapfumaneyi, P.; Lelasseur, P.; Carlo, L.; Jude, A.; Bourg, A.L.; Panchal, B.; Dick, A.; et al. The Pandemic and Your Skin—Direct and Indirect Impact of COVID-19. Cosmetics 2023, 10, 34. [Google Scholar] [CrossRef]
- Latter, G.; Grice, J.E.; Mohammed, Y.; Roberts, M.S.; Benson, H.A.E. Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems. Pharmaceutics 2019, 11, 490. [Google Scholar] [CrossRef]
- Wittkowski, A.; Richards, H.L.; Griffiths, C.E.; Main, C.J. The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. J. Psychosom. Res. 2004, 57, 195–200. [Google Scholar] [CrossRef] [PubMed]
- Gupta, D. Atopic Dermatitis: A Common Pediatric Condition and Its Evolution in Adulthood. Med. Clin. N. Am. 2015, 99, 1269–1285, xii. [Google Scholar] [CrossRef]
- Marko, M.; Pawliczak, R. Skin infections during dupilumab monotherapy in moderate-to-severe atopic dermatitis—A meta-analysis of randomized clinical trials. Expert Rev. Clin. Immunol. 2024, 20, 121–134. [Google Scholar] [CrossRef] [PubMed]
- Mohammed, Y.H.; Moghimi, H.R.; Yousef, S.A.; Chandrasekaran, N.C.; Bibi, C.R.; Sukumar, S.C.; Grice, J.E.; Sakran, W.; Roberts, M.S. Efficacy, Safety and Targets in Topical and Transdermal Active and Excipient Delivery. In Percutaneous Penetration Enhancers Drug Penetration Into/Through the Skin—Methodology and General Considerations; Dragicevic, N., Maibach, H.I., Eds.; Springer: Berlin/Heidelberg, Germany, 2017; pp. 369–391. [Google Scholar]
- Crowther, J.; Sieg, A.; Blenkiron, P.; Marcott, C.; Matts, P.; Kaczvinsky, J.; Rawlings, A. Measuring the effects of topical moisturizers on changes in stratum corneum thickness, water gradients and hydration In Vivo. Br. J. Dermatol. 2008, 159, 567–577. [Google Scholar] [PubMed]
- Menon, G.K.; Cleary, G.W.; Lane, M.E. The structure and function of the stratum corneum. Int. J. Pharm. 2012, 435, 3–9. [Google Scholar] [CrossRef] [PubMed]
- Ridd, M.J.; Wells, S.; Edwards, L.; Santer, M.; MacNeill, S.; Sanderson, E.; Sutton, E.; Shaw, A.R.; Banks, J.; Garfield, K. Best emollients for eczema (BEE)–comparing four types of emollients in children with eczema: Protocol for randomised trial and nested qualitative study. BMJ Open 2019, 9, e033387. [Google Scholar] [CrossRef] [PubMed]
- Leite-Silva, V.R.; Grice, J.E.; Mohammed, Y.; Moghimi, H.R.; Roberts, M.S. The Influence of Emollients on Dermal and Transdermal Drug Delivery. In Percutaneous Penetration Enhancers Drug Penetration Into/Through the Skin; Dragicevic, N., Maibach, H.I., Eds.; Springer: Berlin/Heidelberg, Germany, 2017; pp. 77–93. [Google Scholar]
- Aubert-Wastiaux, H.; Moret, L.; Le Rhun, A.; Fontenoy, A.; Nguyen, J.; Leux, C.; Misery, L.; Young, P.; Chastaing, M.; Danou, N. Topical corticosteroid phobia in atopic dermatitis: A study of its nature, origins and frequency. Br. J. Dermatol. 2011, 165, 808–814. [Google Scholar] [CrossRef]
- Harding, C.R.; Watkinson, A.; Rawlings, A.V.; Scott, I.R. Dry skin, moisturization and corneodesmolysis. Int. J. Cosmet. Sci. 2000, 22, 21–52. [Google Scholar] [CrossRef] [PubMed]
- Roberts, M.S.; Mohammed, Y.; Pastore, M.N.; Namjoshi, S.; Yousef, S.; Alinaghi, A.; Haridass, I.N.; Abd, E.; Leite-Silva, V.R.; Benson, H.; et al. Topical and cutaneous delivery using nanosystems. J. Control Release 2017, 247, 86–105. [Google Scholar] [CrossRef]
- Roberts, M.S.; Cheruvu, H.S.; Mangion, S.E.; Alinaghi, A.; Benson, H.A.E.; Mohammed, Y.; Holmes, A.; van der Hoek, J.; Pastore, M.; Grice, J.E. Topical drug delivery: History, percutaneous absorption, and product development. Adv. Drug. Deliv. Rev. 2021, 177, 113929. [Google Scholar] [CrossRef]
- Yousef, S.A.; Mohammed, Y.H.; Namjoshi, S.; Grice, J.E.; Benson, H.A.E.; Sakran, W.; Roberts, M.S. Mechanistic Evaluation of Enhanced Curcumin Delivery through Human Skin In Vitro from Optimised Nanoemulsion Formulations Fabricated with Different Penetration Enhancers. Pharmaceutics 2019, 11, 639. [Google Scholar] [CrossRef]
- Namjoshi, S.; Dabbaghi, M.; Roberts, M.S.; Grice, J.E.; Mohammed, Y. Quality by Design: Development of the Quality Target Product Profile (QTPP) for Semisolid Topical Products. Pharmaceutics 2020, 12, 287. [Google Scholar] [CrossRef]
- Danby, S.G.; Draelos, Z.D.; Gold, L.F.S.; Cha, A.; Vlahos, B.; Aikman, L.; Sanders, P.; Wu-Linhares, D.; Cork, M.J. Vehicles for atopic dermatitis therapies: More than just a placebo. J. Dermatol. Treat. 2022, 33, 685–698. [Google Scholar] [CrossRef]
- Rawlings, A.V.; Canestrari, D.A.; Dobkowski, B. Moisturizer technology versus clinical performance. Dermatol. Ther. 2004, 17, 49–56. [Google Scholar] [CrossRef] [PubMed]
- Chang, R.-K.; Raw, A.; Lionberger, R.; Yu, L. Generic development of topical dermatologic products: Formulation development, process development, and testing of topical dermatologic products. AAPS J. 2013, 15, 41–52. [Google Scholar] [CrossRef] [PubMed]
- Herbig, M.E.; Evers, D.-H.; Gorissen, S.; Köllmer, M. Rational Design of Topical Semi-Solid Dosage Forms-How Far Are We? Pharmaceutics 2023, 15, 1822. [Google Scholar] [CrossRef]
- Surber, C.; Smith, E.W. The mystical effects of dermatological vehicles. Dermatology 2005, 210, 157–168. [Google Scholar] [CrossRef]
- Roure, R.; Lanctin, M.; Nollent, V.; Bertin, C. Methods to Assess the Protective Efficacy of Emollients against Climatic and Chemical Aggressors. Dermatol. Res. Pract. 2012, 2012, 864734. [Google Scholar] [CrossRef] [PubMed]
- Proksch, E.; Lachapelle, J.M. The management of dry skin with topical emollients--recent perspectives. J. Dtsch. Dermatol. Ges. 2005, 3, 768–774. [Google Scholar] [CrossRef]
- Elias, P.M. Optimizing emollient therapy for skin barrier repair in atopic dermatitis. Ann. Allergy Asthma Immunol. 2022, 128, 505–511. [Google Scholar] [CrossRef]
- Mayba, J.N.; Gooderham, M.J. A guide to topical vehicle formulations. J. Cutan. Med. Surg. 2018, 22, 207–212. [Google Scholar] [CrossRef] [PubMed]
- United States Pharmacopoeial Convention. The United States pharmacopoeia: The National Formulary; United States Pharmacopoeial Convention: Rockville, MD, USA, 2019. [Google Scholar]
- Simoes, A.; Veiga, F.; Vitorino, C.; Figueiras, A. A Tutorial for Developing a Topical Cream Formulation Based on the Quality by Design Approach. J. Pharm. Sci. 2018, 107, 2653–2662. [Google Scholar] [CrossRef]
- Torres, A.; Almeida, I.F.; Oliveira, R. An Overview of Proprietary Vehicles/Bases for Topical Compounding Medicines and Cosmetics. Cosmetics 2024, 11, 16. [Google Scholar] [CrossRef]
- Weiss, S.C. Conventional topical delivery systems. Dermatol. Ther. 2011, 24, 471–476. [Google Scholar] [CrossRef]
- Devaux, S.; Castela, A.; Archier, E.; Gallini, A.; Joly, P.; Misery, L.; Aractingi, S.; Aubin, F.; Bachelez, H.; Cribier, B. Adherence to topical treatment in psoriasis: A systematic literature review. J. Eur. Acad. Dermatol. Venereol. 2012, 26, 61–67. [Google Scholar] [CrossRef]
- Kulawik-Pioro, A.; Ptaszek, A.; Kruk, J. Effective tool for assessment of the quality of barrier creams-relationships between rheological, textural and sensory properties. Regul. Toxicol. Pharmacol. 2019, 103, 113–123. [Google Scholar] [CrossRef]
- Kwak, M.-S.; Ahn, H.-J.; Song, K.-W. Rheological investigation of body cream and body lotion in actual application conditions. Korea-Aust. Rheol. J. 2015, 27, 241–251. [Google Scholar] [CrossRef]
- Buhse, L.; Kolinski, R.; Westenberger, B.; Wokovich, A.; Spencer, J.; Chen, C.W.; Turujman, S.; Gautam-Basak, M.; Kang, G.J.; Kibbe, A. Topical drug classification. Int. J. Pharm. 2005, 295, 101–112. [Google Scholar] [CrossRef]
- Huang, X.; Tanojo, H.; Lenn, J.; Deng, C.H.; Krochmal, L. A novel foam vehicle for delivery of topical corticosteroids. J. Am. Acad. Dermatol. 2005, 53, S26–S38. [Google Scholar] [CrossRef]
- Araviiskaia, E.; Lopez Estebaranz, J.L.; Pincelli, C. Dermocosmetics: Beneficial adjuncts in the treatment of acne vulgaris. J. Dermatol. Treat. 2021, 32, 3–10. [Google Scholar] [CrossRef]
- Ricciatti-Sibbald, D.; Sibbald, R.G. Dermatologic vehicles. Clin. Dermatol. 1989, 7, 11–24. [Google Scholar] [CrossRef]
- Dreno, B.; Araviiskaia, E.; Berardesca, E.; Bieber, T.; Hawk, J.; Sanchez-Viera, M.; Wolkenstein, P. The science of dermocosmetics and its role in dermatology. J. Eur. Acad. Dermatol. Venereol. 2014, 28, 1409–1417. [Google Scholar] [CrossRef]
- Brandt, F.S.; Cazzaniga, A.; Hann, M. Cosmeceuticals: Current trends and market analysis. Semin. Cutan. Med. Surg. 2011, 30, 141–143. [Google Scholar] [CrossRef] [PubMed]
- Newburger, A.E. Cosmeceuticals: Myths and misconceptions. Clin. Dermatol. 2009, 27, 446–452. [Google Scholar] [CrossRef]
- Guerrero, D. Approche dermo-cosmétique de l’acné chez le dermatologue. Ann. De Dermatol. Et De Vénéréologie 2010, 137, S76–S80. [Google Scholar] [CrossRef] [PubMed]
- Kurokawa, I.; Kobayashi, M.; Nomura, Y.; Abe, M.; Kerob, D.; Dreno, B. The role and benefits of dermocosmetics in acne management in japan. Dermatol. Ther. 2023, 13, 1423–1433. [Google Scholar] [CrossRef] [PubMed]
- Külkamp-Guerreiro, I.; Berlitz, S.; Contri, R.; Alves, L.; Henrique, E.; Barreiros, V.; Guterres, S. Influence of nanoencapsulation on the sensory properties of cosmetic formulations containing lipoic acid. Int. J. Cosmet. Sci. 2013, 35, 105–111. [Google Scholar] [CrossRef] [PubMed]
- Purnamawati, S.; Indrastuti, N.; Danarti, R.; Saefudin, T. The role of moisturizers in addressing various kinds of dermatitis: A review. Clin. Med. Res. 2017, 15, 75–87. [Google Scholar] [CrossRef]
- Spada, F.; Barnes, T.M.; Greive, K.A. Skin hydration is significantly increased by a cream formulated to mimic the skin’s own natural moisturizing systems. Clin. Cosmet. Investig. Dermatol. 2018, 11, 491–497. [Google Scholar] [CrossRef] [PubMed]
- Lodén, M. Effect of moisturizers on epidermal barrier function. Clin. Dermatol. 2012, 30, 286–296. [Google Scholar] [CrossRef] [PubMed]
- Danby, S.G.; Andrew, P.V.; Taylor, R.N.; Kay, L.J.; Chittock, J.; Pinnock, A.; Ulhaq, I.; Fasth, A.; Carlander, K.; Holm, T. Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis. Clin. Exp. Dermatol. 2022, 47, 1154–1164. [Google Scholar] [CrossRef]
- Loden, M. The clinical benefit of moisturizers. J. Eur. Acad. Dermatol. Venereol. 2005, 19, 672–688. [Google Scholar] [CrossRef]
- Ghadially, R.; Halkier-Sorensen, L.; Elias, P.M. Effects of petrolatum on stratum corneum structure and function. J. Am. Acad. Dermatol. 1992, 26, 387–396. [Google Scholar] [CrossRef]
- Mawazi, S.M.; Ann, J.; Othman, N.; Khan, J.; Alolayan, S.O.; Al thagfan, S.S.; Kaleemullah, M. A review of moisturizers; history, preparation, characterization and applications. Cosmetics 2022, 9, 61. [Google Scholar] [CrossRef]
- Draelos, Z.D. The science behind skin care: Moisturizers. J. Cosmet. Dermatol. 2018, 17, 138–144. [Google Scholar] [CrossRef] [PubMed]
- Kovács, A.; Péter-Héderi, D.; Perei, K.; Budai-Szűcs, M.; Léber, A.; Gácsi, A.; Csányi, E.; Berkó, S. Effects of formulation excipients on skin barrier function in creams used in pediatric care. Pharmaceutics 2020, 12, 729. [Google Scholar] [CrossRef] [PubMed]
- Youssef, R.; Hafez, V.; Elkholy, Y.; Mourad, A. Glycerol 85% efficacy on atopic skin and its microbiome: A randomized controlled trial with clinical and bacteriological evaluation. J. Dermatol. Treat. 2021, 32, 730–736. [Google Scholar] [CrossRef] [PubMed]
- Lanigan, R.S.; Yamarik, T.A. Final Report on the Safety Assessment of EDTA, Calcium Disodium EDTA, Diammonium EDTA, Dipotassium EDTA, Disodium EDTA, TEA-EDTA, Tetrasodium EDTA, Tripotassium EDTA, Trisodium EDTA, HEDTA, and Trisodium HEDTA. Int. J. Toxicol. 2002, 21, 95–142. [Google Scholar] [CrossRef]
- Chandan, N.; Rajkumar, J.R.; Shi, V.Y.; Lio, P.A. A new era of moisturizers. J. Cosmet. Dermatol. 2021, 20, 2425–2430. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Y.; Heinemann, N.; Rademacher, F.; Darvin, M.E.; Raab, C.; Keck, C.M.; Vollert, H.; Fluhr, J.W.; Gläser, R.; Harder, J. Skin care product rich in antioxidants and anti-inflammatory natural compounds reduces itching and inflammation in the skin of atopic dermatitis patients. Antioxidants 2022, 11, 1071. [Google Scholar] [CrossRef] [PubMed]
- Deza, G.; Giménez-Arnau, A.M. Allergic contact dermatitis in preservatives: Current standing and future options. Curr. Opin. Allergy Clin. Immunol. 2017, 17, 263–268. [Google Scholar] [CrossRef]
- Pónyai, G.; Németh, I.; Nagy, G.; Fábos, B.; Irinyi, B.; Dinnyés, M.; Altmayer, A.; Temesvári, E. Methylchloroisothiazolinone/methylisothiazolinone and methylisothiazolinone hypersensitivity in 1122 patients: A national multicenter study organized by the Hungarian Contact Dermatitis Group. Contact Dermat. 2019, 81, 467–469. [Google Scholar] [CrossRef]
- Botvid, S.; Simonsen, A.B.; Jørgensen, C.; Müller, S.; Kirkeby, C.S.; Christensen, A.B.; Johansen, J.D. Fragrance allergens in cosmetic products marketed for children in Denmark. Contact Dermat. 2023, 89, 374–381. [Google Scholar] [CrossRef]
- Travassos, A.R.; Claes, L.; Boey, L.; Drieghe, J.; Goossens, A. Non-fragrance allergens in specific cosmetic products. Contact Dermat. 2011, 65, 276–285. [Google Scholar] [CrossRef] [PubMed]
Excipient | Role | Example | Other Function |
---|---|---|---|
Solvents [32,34,64] | vehicle, dissolve excipients | water, propylene glycol, mineral oil, and hexylene glycol | water, the most essential and commonly |
Consistency agents [6,34] | hardening or consistency | beeswax, carnauba wax, white petrolatum, liquid paraffin, and lanolin | protective occlusive barrier |
Thickeners/Gelling agents [6,32,34] | viscosity control | cetyl alcohol, cetearyl alcohol, carnauba wax, stearic acid, gelatin, hydroxyethyl cellulose, xanthan gum, carboxymethyl cellulose, guar gum, sodium alginate, bentonite, aluminum magnesium silicate, ammonium acryloyldimethyltaurate, silica, acetyl palmitate, carbomers | viscosity is directly related to skin retention and the penetration of actives |
Silicones [6,32] | smooth skin surface | dimethicone, cyclomethicone | ingredients that can act as non-greasy occlusives |
Humectants [65,67] | attract water | glycerin | accelerate skin barrier recovery |
Emulsifiers/Solubilisers [6,34] | stability control | glycerol monostearate, cetostearyl alcohol, cetyl palmitate, sorbitan monostearate, polysorbate 20, polysorbate 60, polysorbate 80, propylene glycol monostearate, sorbitan monooleate, poloxamer, emulsifying wax, sodium lauryl sulfate, and diethylene glycol monoethyl ether | higher percentage can cause dermal irritation, corrosiveness, and an increased potential for sensitization |
Chelating agents [6] | improve the stability of a topical vehicle | EDTA | may exhibit positive synergy with the effects of preservatives |
Acidifying/Alkalising/Buffering agent [6,32,34] | buffering, pH agent | citric acid, phosphoric acid, lactic acid, and sodium hydroxide | correct skin pH; help to delivery of actives; and maintaining the stability and efficacy of an active ingredient |
Antioxidants [6] | composition protection | BHA, BHT, ascorbyl palmitate, and sodium ascorbate | prevent oil rancidity |
Preservatives [6] | prevent contamination | benzyl alcohol, ethanol, phenoxyethanol, quaternary ammonium compounds (benzalkonium chloride, cetrimide), hydroxybenzoates (all salts), phenols (chlorocresol) | extend shelf life |
Fragrance [6,73] | perfume the product | natural or synthetic origin | attractiveness of cosmetic products |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kurebayashi, A.K.; Phan, K.; Abdoh, A.; Andreo-Filho, N.; Lopes, P.S.; Mohammed, Y.; Leite-Silva, V.R. Strategic Approaches in Formulation Development for Atopic Dermatitis. Cosmetics 2024, 11, 113. https://doi.org/10.3390/cosmetics11040113
Kurebayashi AK, Phan K, Abdoh A, Andreo-Filho N, Lopes PS, Mohammed Y, Leite-Silva VR. Strategic Approaches in Formulation Development for Atopic Dermatitis. Cosmetics. 2024; 11(4):113. https://doi.org/10.3390/cosmetics11040113
Chicago/Turabian StyleKurebayashi, Alberto Keidi, Khanh Phan, Ayyah Abdoh, Newton Andreo-Filho, Patricia Santos Lopes, Yousuf Mohammed, and Vania Rodrigues Leite-Silva. 2024. "Strategic Approaches in Formulation Development for Atopic Dermatitis" Cosmetics 11, no. 4: 113. https://doi.org/10.3390/cosmetics11040113
APA StyleKurebayashi, A. K., Phan, K., Abdoh, A., Andreo-Filho, N., Lopes, P. S., Mohammed, Y., & Leite-Silva, V. R. (2024). Strategic Approaches in Formulation Development for Atopic Dermatitis. Cosmetics, 11(4), 113. https://doi.org/10.3390/cosmetics11040113